Review Article

Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress

Table 3

SPMs in ROS-mediated chronic inflammatory diseases.

SPMDiseasesReferences

LXA4Ischemia/reperfusion[3133]
LXA4Alzheimer’s disease[42]
LXA4Arthritis[43]
LXA4Asthma[44]
LXA4Inflammatory bowel disease[47]
LXsDiabetes[45]
LXsCardiovascular diseases[46]
RvE1Inflammatory bowel disease[6]
RvE1Cardiovascular diseases[6, 46]
RvD1COPD and lung ischemia/reperfusion[10, 65, 67, 68, 75]
RvD2Lung ischemia/reperfusion[75]
RvD1Atherosclerosis[46]
MaR1Lung ischemia/reperfusion[66, 82, 85]
MaR1Cardiovascular diseases[46, 79, 80]
MaR1Diabetes[84]
PD1Diabetes[92]
PD1Cardiovascular diseases[46, 78]
PD1Neurodegenerative diseases[8991]